Skip to main content

Table 3 Comparison of the median prices of the inhaled and oral generic and originator asthma and COPD medicine brands

From: Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective

Generic brands Median (IQR) price in UgX Median (IQR) price in USD Originator brands Median (IQR) price in UgX Median (IQR) price in USD
Salbutamol 100 μg 10,000 (9000–13,000) 2.8 (2.5–3.6) Ventolin 100 μg 12,000 (10000–15,000) 3.3 (2.8–4.2)
Ipratropium bromide 20 μg 60,000 (48500–65,000) 16.7 (13.5–18.1) Atrovent 20 μg 62,500 (60000–65,000) 17.4 (16.7–18.1)
Ipratropium 40 μg 64,000 (56750–65,000) 17.8 (15.8–18.1) Atrovent 40 μg 65,000 (65000–70,000) 18.1 (18.1–19.4)
Salbutamol/ipratropium 100/20 μg 50,000 (35000–65,000) 13.9 (9.7–18.1) Combivent 100/20 μg 40,000 (30000–50,000) 11.1 (8.3–13.9)
Formoterol-budesonide 4.5/160 μg 80,000 (45000–85,000) 22.2 (12.5–23.6) Symbicort 4.5/160 μg 100,000 (85000–120,000) 27.8 (23.6–33.3)
Salmeterol-fluticasone propionate 25/125 μg 48,000 (35000–50,000) 13.3 (9.7–13.9) Seretide 25/125 μg 50,000 (48000–60,000) 13.9 (13.3–16.7)
Budesonide 200 μg 37,500 (33000–42,000) 10.4 (9.2–11.7) Pulmicort 200 μg 100,000 (75000–130,000) 27.8 (20.8–36.1)
Fluticasone propionate 250 μg 25,000 (25000–26,000) 6.9 (6.9–7.2) Flixotide 250 μg 87,500 (80000–95,000) 24.3 (22.2–26.4)
Fluticasone propionate 125 μg 27,000 (25000–40,000) 7.5 (6.9–11.1) Flixotide 125 μg 87,500 (87500–87,500) 24.3 (24.3–24.3)
Fluticasone propionate 50 μg 27,500 (25000–30,000) 7.6 (6.9–8.3) Flixotide 50 μg) 78,500 (78500–78,500) 21.8 (21.8–21.8)
Tablets montelukast 10 mg 1000 (800–1200) 0.3 (0.2–0.3) Singular 10 mg 1100 (900–1400) 0.3 (0.3–0.4)
Tablets montelukast 20 mg 1200 (1000–1500) 0.3 (0.3–0.4) Singular 20 mg 1200 (1100–1500) 0.3 (0.3–0.4)
  1. IQR-Inter-quartile range, UgX-Uganda shillings, USD-US dollars